These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 32093876

  • 1. Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.
    Beaton L, Dunne EM, Yeung R, Rackley T, Weber B, Mar C, Yong-Hing CJ, Yoshida EM, DeVries K, Lee R, Duzenli C, Loewen SK, Liu M, Schellenberg D, Ma R.
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):423-432. PubMed ID: 32093876
    [Abstract] [Full Text] [Related]

  • 2. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
    Yeung R, Beaton L, Rackley T, Weber B, Hamm J, Lee R, Camborde M, Pearson M, Duzenli C, Loewen SK, Liu M, Ma R, Schellenberg D.
    Clin Oncol (R Coll Radiol); 2019 Jun; 31(6):365-373. PubMed ID: 30792051
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY, Lee Y, McLean K, Leggett D, Hodgkinson P, Fawcett J, Mott R, Stuart K, Pryor D.
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e194-e202. PubMed ID: 32345457
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities.
    Que JY, Lin LC, Lin KL, Lin CH, Lin YW, Yang CC.
    Radiat Oncol; 2014 May 28; 9():120. PubMed ID: 24885086
    [Abstract] [Full Text] [Related]

  • 5. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):355-61. PubMed ID: 22342300
    [Abstract] [Full Text] [Related]

  • 6. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL, Johnson CS, Maluccio M, Kwo P, Tector AJ, Zook J, Johnstone PA, Cardenes HR.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e447-53. PubMed ID: 21645977
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D'Agostino G, Iftode C, Mancosu P, Ceriani R, Torzilli G.
    J Cancer Res Clin Oncol; 2015 Jul 15; 141(7):1301-9. PubMed ID: 25644863
    [Abstract] [Full Text] [Related]

  • 9. Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma.
    Que J, Kuo HT, Lin LC, Lin KL, Lin CH, Lin YW, Yang CC.
    BMC Cancer; 2016 Jul 12; 16():451. PubMed ID: 27405814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion.
    Mathew AS, Atenafu EG, Owen D, Maurino C, Brade A, Brierley J, Dinniwell R, Kim J, Cho C, Ringash J, Wong R, Cuneo K, Feng M, Lawrence TS, Dawson LA.
    Eur J Cancer; 2020 Jul 12; 134():41-51. PubMed ID: 32460180
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS, Lu HZ, Cheng T, Zhou Y, Huang Y, Gao YC, Tang MY, Jiang HY, Lian ZP, Hou EC, Liang P.
    BMC Cancer; 2016 Nov 03; 16(1):834. PubMed ID: 27809890
    [Abstract] [Full Text] [Related]

  • 14. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R, Grosu AL, Brunner TB.
    Radiat Oncol; 2017 Jul 12; 12(1):116. PubMed ID: 28701219
    [Abstract] [Full Text] [Related]

  • 15. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E.
    Acta Oncol; 2014 Mar 12; 53(3):399-404. PubMed ID: 23962244
    [Abstract] [Full Text] [Related]

  • 16. Stereotactic body radiation therapy for early hepatocellular carcinoma: a retrospective analysis of the South Australian experience.
    Wigg AJ, Narayana SK, Le H, Iankov I, Chinnaratha MA, Tse E, Chen JW, Gowda R.
    ANZ J Surg; 2019 Sep 12; 89(9):1138-1143. PubMed ID: 30983104
    [Abstract] [Full Text] [Related]

  • 17. Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.
    Kim JW, Seong J, Lee IJ, Woo JY, Han KH.
    Oncotarget; 2016 Jun 28; 7(26):40756-40766. PubMed ID: 27213593
    [Abstract] [Full Text] [Related]

  • 18. Stereotactic body radiation therapy for small (≤5 cm) hepatocellular carcinoma not amenable to curative treatment: Results of a single-arm, phase II clinical trial.
    Yoon SM, Kim SY, Lim YS, Kim KM, Shim JH, Lee D, An J, Jung J, Kim JH, Lee HC.
    Clin Mol Hepatol; 2020 Oct 28; 26(4):506-515. PubMed ID: 32646200
    [Abstract] [Full Text] [Related]

  • 19. Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma.
    Culleton S, Jiang H, Haddad CR, Kim J, Brierley J, Brade A, Ringash J, Dawson LA.
    Radiother Oncol; 2014 Jun 28; 111(3):412-7. PubMed ID: 24906626
    [Abstract] [Full Text] [Related]

  • 20. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
    Gerum S, Heinz C, Belka C, Walter F, Paprottka P, De Toni EN, Roeder F.
    Radiat Oncol; 2018 May 29; 13(1):100. PubMed ID: 29843752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.